IPUBLIC RECORDSEXCHANGERECEIPTSloadinglive·IMONEY TRAILEXCHANGESOURCESverifyinglive·IDATA SOURCESEXCHANGEFILINGSpublic recordslive·IPUBLIC RECORDSEXCHANGERECEIPTSloadinglive·IMONEY TRAILEXCHANGESOURCESverifyinglive·IDATA SOURCESEXCHANGEFILINGSpublic recordslive·
← Ticker index
ELV
Ticker

ELV

Congressional Trades
113
by 12 members
Ticker disclosure brief

Congressional disclosure records for ELV

A ticker-first view of recent disclosures, reported ranges, filing lags, party aggregates, federal awards, lobbying records, and source-linked receipts.

Latest receipt
Ro Khanna
BUY · 2026-05-15
Largest range
$100K – $250K
Michael McCaul
Longest observed gap
318d
Valerie Hoyle
Highest 30d vs SPY
36.0%
Ro Khanna
Purchase rows
51
45%
Sale rows
60
53%
Disclosed midpoint
$2.2M
range estimate
Unique Traders
12
members
Disclosure timing method

Observed filing gaps are not notice-date findings

The reporting deadline is the earlier of 30 days after notice or 45 days after the transaction. Public disclosure rows provide transaction and filing dates, but do not establish when a member received notice. PoliWealth therefore marks only transaction-to-filing gaps over 45 days as an apparent delay for review; 31–45 day gaps are not labeled late from transaction date alone.

Party Breakdown

Democrats68 · 60%
Republicans45 · 40%

Lobbying filings

all →
  • 2026-04-30$1.7M
    ELEVANCE HEALTH INC.
    ACA Exchanges & Enrollment Enhanced Premium Tax Credits The Lower Health Care Premiums for All Americans Act (H.R. 6703) Prior Authorization Mental Health Parity Facilitating Accountability in Reimbursements Act (FAIR Act) (118th Congress) Site-based Invoicing and Transparency Enhancement (SITE) Act (118th Congress) Lower Cost, More Transparency Act (118th Congress) AI Use in Healthcare Health Disparities, including Maternal Health and Rural Health Veterans Assuring Critical Care Expansions to Support Servicemembers (ACCESS) Act of 2025 (S. 275 and H.R. 7040) Veterans Affairs Community Cares program GUARD Veterans Health Care Act (H.R. 4077) Provider Directories Transparency in Coverage and Machine-Readable Files Patients Deserve Price Tags Act (H.R. 5582 & S. 2355) No Surprises Act Implementation No Suprises Act Enforcement Act (H.R. 4710) Physician Led and Rural Access to Quality Care Act (H.R. 2191) One Big Beautiful Bill Act (H.R. 1) Consolidated Appropriations Act of 2026 (H.R.714
  • 2026-04-21$60K
    ELEVANCE HEALTH INC
    Issues related to Pharmacy Benefit Managers, Medicare Advantage, and health insurance. Issues surrounding risk adjustment. Issues related to Pharmacy Benefit Managers, Medicare Advantage, and health insurance. Issues relating to extension of Enhanced Advanced Premium Tax Credits (EAPTCs) Issues related to No Surprises Act implementation.
  • 2026-04-20$2.1M
    ELEVANCE HEALTH INC.
    ACA Exchanges & Enrollment Enhanced Premium Tax Credits The Lower Health Care Premiums for All Americans Act (H.R. 6703) Prior Authorization Mental Health Parity Facilitating Accountability in Reimbursements Act (FAIR Act) (118th Congress) Site-based Invoicing and Transparency Enhancement (SITE) Act (118th Congress) Lower Cost, More Transparency Act (118th Congress) AI Use in Healthcare Health Disparities, including Maternal Health and Rural Health Veterans Assuring Critical Care Expansions to Support Servicemembers (ACCESS) Act of 2025 (S. 275 and H.R. 7040) Veterans Affairs Community Cares program GUARD Veterans Health Care Act (H.R. 4077) Provider Directories Transparency in Coverage and Machine-Readable Files Patients Deserve Price Tags Act (H.R. 5582 & S. 2355) No Surprises Act Implementation No Suprises Act Enforcement Act (H.R. 4710) Physician Led and Rural Access to Quality Care Act (H.R. 2191) One Big Beautiful Bill Act (H.R. 1) Consolidated Appropriations Act of 2026 (H.R.714
  • 2026-04-20$90K
    ELEVANCE HEALTH INC.
    Issues related to health insurance price transparency. Issues related to prescription drug costs and delivery. Medicare Advantage, Medicare Part D, Medicaid Managed Care. Issues related to prescription drug costs and delivery. PBM Reform issues. CY 2027 Medicare Advantage Rate Notice. Prescription Drug Pricing. Issues related to enhanced premium tax credits, and tax-preferred accounts to help lower the cost of insurance.
  • 2026-04-20$80K
    ELEVANCE HEALTH INC (F.K.A. ANTHEM INC. & WELLPOINT INC.)
    Federal budget issues Access and affordability, telehealth coverage, social determinates of health, health savings accounts Medicare & Medicaid reimbursement and coverage issues, Medicare Advantage health care access and quality issues Issues related to tax advantage savings vehicles for health expenses
  • 2026-04-19$90K
    ELEVANCE HEALTH INC.
    Issues related to the Medicare Advantage and Medicaid programs.
  • 2026-04-17$75K
    ELEVANCE HEALTH
    PBM reform, ACA tax credits, and Medicaid policy
  • 2026-04-15$60K
    ELEVANCE HEALTH INC.
    No Surprises Act implementation and health care payment policy.
  • 2026-01-20$1.5M
    ELEVANCE HEALTH INC.
    ACA Exchanges & Enrollment Enhanced Advanced Premium Tax Credits The Lower Health Care Premiums for All Americans Act (H.R. 6703) Prior Authorization Mental Health Parity Facilitating Accountability in Reimbursements Act (FAIR Act (118th Congress) Site-based Invoicing and Transparency Enhancement (SITE) Act (118th Congress) Lower Cost, More Transparency Act (118th Congress) AI Use in Healthcare Health Disparities, including Maternal Health and Rural Health Veterans Assuring Critical Care Expansions to Support Servicemembers (ACCESS) Act of 2025 (S. 275 and H.R. 740) Veterans Affairs Community Cares program GUARD Veterans Health Care Act (H.R. 4077) Provider Directories Transparency in Coverage and Machine-Readable Files No Surprises Act Implementation Physician Led and Rural Access to Quality Care Act (H.R. 2191) One Big Beautiful Bill Act (H.R. 1) ACA Exchanges & Enrollment Enhanced Advanced Premium Tax Credits The Lower Health Care Premiums for All Americans Act (H.R. 6703) Prior A
  • 2026-01-20$90K
    ELEVANCE HEALTH INC.
    Prescription Drug Pricing. Issues related to advanced premium tax credits. PL 119-21, An act to provide for reconciliation pursuant to title II of H. Res. Con. 14. Issues related to health insurance price transparency. Issues related to prescription drug costs and delivery. PL 119-21, An act to provide for reconciliation pursuant to title II of H. Res. Con. 14. Medicare Advantage, Medicare Part D, Medicaid Managed Care. Issues related to prescription drug costs and delivery. PBM Reform issues. PL 119-21, An act to provide for reconciliation pursuant to title II of H. Res. Con. 14.
Loading trade analytics…

All Disclosed Trades

Page 4 · 25 of 113 shown
DateMemberActionAmountObserved GapReceipt
2025-01-13RRobert BresnahanSELL$1K – $15K31dreceipt →
2025-01-09RMichael McCaulSELL$15K – $50K33dreceipt →
2025-01-09RMichael McCaulSELL$15K – $50K33dreceipt →
2024-11-19RMichael McCaulSELL$15K – $50K27dreceipt →
2024-11-19RMichael McCaulSELL$15K – $50K27dreceipt →
2024-11-08DJared MoskowitzBUY$1K – $15K31dreceipt →
2024-11-08DJared MoskowitzBUY$1K – $15K31dreceipt →
2024-11-12DRo KhannaSELL$1K – $15K23dreceipt →
2024-11-12DRo KhannaSELL$1K – $15K23dreceipt →
2024-11-15DRo KhannaSELL$1K – $15K20dreceipt →
2024-11-15DRo KhannaSELL$1K – $15K20dreceipt →
2024-08-26RMichael McCaulSELL$50K – $100K21dreceipt →
2024-08-26RMichael McCaulSELL$50K – $100K21dreceipt →
2024-09-04RJohn JamesSELL$1K – $15K2dreceipt →
2024-08-02DRo KhannaSELL$1K – $15K35dreceipt →
2024-09-04RJohn JamesSELL$1K – $15K2dreceipt →
2024-08-02DRo KhannaSELL$1K – $15K35dreceipt →
2024-02-13DJared MoskowitzBUY$1K – $15K190dApparent delayreceipt →
2024-02-13DJared MoskowitzBUY$1K – $15K190dApparent delayreceipt →
2024-02-01DJared MoskowitzBUY$1K – $15K202dApparent delayreceipt →
2024-02-01DJared MoskowitzBUY$1K – $15K187dApparent delayreceipt →
2024-07-01DJared MoskowitzBUY$1K – $15K36dreceipt →
2024-07-05DJared MoskowitzBUY$1K – $15K32dreceipt →
2024-07-05DJared MoskowitzBUY$1K – $15K32dreceipt →
2024-07-01DJared MoskowitzBUY$1K – $15K36dreceipt →

“Observed gap” is the calendar distance from transaction date to filing date; only gaps over 45 days receive an apparent-delay marker.